(Q31562134)

English

125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 July 2017

125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors (English)

1 reference

Europe PubMed Central

2 July 2017

author name string

Higelin J

1

1 reference

Europe PubMed Central

2 July 2017

Py-Lang G

2

1 reference

Europe PubMed Central

2 July 2017

Paternoster C

3

1 reference

Europe PubMed Central

2 July 2017

Ellis GJ

4

1 reference

Europe PubMed Central

2 July 2017

Patel A

5

1 reference

Europe PubMed Central

2 July 2017

Dautzenberg FM

6

1 reference

Europe PubMed Central

2 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2001

1 reference

Europe PubMed Central

2 July 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Neuropharmacology

1 reference

Europe PubMed Central

2 July 2017

40

1 reference

Europe PubMed Central

2 July 2017

114-122

1 reference

Europe PubMed Central

2 July 2017

1

1 reference

Europe PubMed Central

2 July 2017

The role of corticotropin-releasing factor in depression and anxiety disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

G proteins in signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Corticotrophin-releasing factor receptors: from molecular biology to drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: unusual pharmacology of the type 1 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Functional characterization of corticotropin-releasing factor type 1 receptor endogenously expressed in human embryonic kidney 293 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Evidence for the abundant expression of arginine 185 containing human CRF(2alpha) receptors and the role of position 185 for receptor-ligand selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Cloning and characterization of human urocortin [published erratum appears in Endocrinoogy 1996 Sep;137(9):3896]

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

7TM receptors: the splicing on the cake

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Urocortin, a novel neuropeptide with anxiogenic-like properties

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Corticotropin-releasing factor receptor type 1 from Tupaia belangeri--cloning, functional expression and tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Isolation and pharmacological characterization of two functional splice variants of corticotropin-releasing factor type 2 receptor from Tupaia belangeri

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Expression and characterisation of human and rat CRF2alpha receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Scintillation proximity assay: a sensitive and continuous isotopic method for monitoring ligand/receptor and antigen/antibody interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Brain and pituitary receptors for corticotropin releasing factor: Localization and differential regulation after adrenalectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900105-2

7 January 2021

Identifiers

10.1016/S0028-3908(00)00105-2

1 reference

Europe PubMed Central

2 July 2017

1 reference

Europe PubMed Central

2 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31562134&oldid=1785966368"